Results 241 to 250 of about 671,308 (289)
Genetic Spatio-Temporal Analysis of Hepatitis D Virus Infection in Western Brazilian Amazon. [PDF]
VirusesRoca TP +8 more
europepmc +1 more source
Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy. [PDF]
JHEP RepMhlanga A +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAMA, 2023
ImportanceHepatitis D virus (HDV) infection occurs in association with hepatitis B virus (HBV) infection and affects approximately 12 million to 72 million people worldwide. HDV causes more rapid progression to cirrhosis and higher rates of hepatocellular carcinoma than HBV alone or hepatitis C virus.ObservationsHDV requires HBV to enter hepatocytes ...
Francesco, Negro, Anna S, Lok
+5 more sources
ImportanceHepatitis D virus (HDV) infection occurs in association with hepatitis B virus (HBV) infection and affects approximately 12 million to 72 million people worldwide. HDV causes more rapid progression to cirrhosis and higher rates of hepatocellular carcinoma than HBV alone or hepatitis C virus.ObservationsHDV requires HBV to enter hepatocytes ...
Francesco, Negro, Anna S, Lok
+5 more sources
Current Treatment Options in Gastroenterology, 2007
The hepatitis delta virus (HDV) is a defective RNA virus that requires the help of hepatitis B virus (HBV) for virion assembly and penetration into hepatocytes. Thus, it can only cause disease in individuals who carry HBV. HDV infection is present worldwide, predominantly in tropical and subtropical areas.
Elif S, Koytak +2 more
openaire +2 more sources
The hepatitis delta virus (HDV) is a defective RNA virus that requires the help of hepatitis B virus (HBV) for virion assembly and penetration into hepatocytes. Thus, it can only cause disease in individuals who carry HBV. HDV infection is present worldwide, predominantly in tropical and subtropical areas.
Elif S, Koytak +2 more
openaire +2 more sources
Journal of Pediatric Gastroenterology and Nutrition, 2016
Sono discussi alcuni aspetti dell'infezione da virus HDV in eta ...
MAGGIORE, Giuseppe +1 more
openaire +3 more sources
Sono discussi alcuni aspetti dell'infezione da virus HDV in eta ...
MAGGIORE, Giuseppe +1 more
openaire +3 more sources
Liver International, 2011
AbstractMore than 30 years after Mario Rizzetto and colleagues described a new antigen in livers of HBsAg‐positive patients called the “delta antigen”, a re‐emerging interest in hepatitis delta is currently observed. The state‐of‐the art on basic and clinical research on hepatitis delta was presented during a monothematic conference organized by the ...
openaire +2 more sources
AbstractMore than 30 years after Mario Rizzetto and colleagues described a new antigen in livers of HBsAg‐positive patients called the “delta antigen”, a re‐emerging interest in hepatitis delta is currently observed. The state‐of‐the art on basic and clinical research on hepatitis delta was presented during a monothematic conference organized by the ...
openaire +2 more sources
Reviews in Medical Virology, 1998
The hepatitis D virus (HDV) relies on the helper hepatitis B virus (HBV) for the provision of its envelope, which consists of hepatitis B surface antigen (HBsAg). The RNA genome of HDV is a circular rod-like structure due to its extensive intramolecular base-pairing.
openaire +2 more sources
The hepatitis D virus (HDV) relies on the helper hepatitis B virus (HBV) for the provision of its envelope, which consists of hepatitis B surface antigen (HBsAg). The RNA genome of HDV is a circular rod-like structure due to its extensive intramolecular base-pairing.
openaire +2 more sources
Seminars in Liver Disease, 2018
AbstractNew therapeutic strategies to treat chronic hepatitis D are directed to deprive the hepatitis D virus (HDV) of functions necessary to complete its life cycle that are provided by the hepatitis B virus (HBV) and by the host. Current options are (1) the block by the synthetic peptide Myrcludex B of HBV surface antigen (HBsAg) entry into cells ...
openaire +2 more sources
AbstractNew therapeutic strategies to treat chronic hepatitis D are directed to deprive the hepatitis D virus (HDV) of functions necessary to complete its life cycle that are provided by the hepatitis B virus (HBV) and by the host. Current options are (1) the block by the synthetic peptide Myrcludex B of HBV surface antigen (HBsAg) entry into cells ...
openaire +2 more sources